For example, high infiltration of activated CD8+ and CD4+ T cells, such as in CMS1 tumors, is associated with good prognosis and less tumor recurrence, although multiple mechanisms of tumor immune evasion could still make these tumors resistant to therapies [23]. This evidence concerns the gene CD4 and neoplasm.